Peeling Back The Layers: Exploring Bristol-Myers Squibb Through Analyst Insights
Latest Ratings for BMY .....»»
Peeling Back The Layers: Exploring Hertz Global Holdings Through Analyst Insights
Latest Ratings for HTZ DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsEqual-Weight Feb 2022Deutsche BankMaintainsBuy Jan 2022BarclaysMaintainsOverweight View More Analyst Ratings for HTZ View the Latest Analyst Ratings read more.....»»
Peeling Back The Layers: Exploring Lincoln Electric Holdings Through Analyst Insights
Latest Ratings for L.....»»
Peeling Back The Layers: Exploring Old National Through Analyst Insights
Latest Ratings for ONB DateFirmAc.....»»
Peeling Back The Layers: Exploring Federal Realty Investment Through Analyst Insights
Latest Ratings for FRT DateFirmActionFromTo Feb 2022MizuhoMaintainsBuy Feb 2022Capital OneUpgradesEqual-WeightOverweight Jan 2022Deutsche BankMaintainsBuy View More Analyst Ratings for FRT View the Latest Analyst Ratings read more.....»»
The Week Ahead In Biotech: Sanofi, Bristol-Myers Squibb Await FDA Decisions, Earnings News Flow Tapers Off
Biotech stocks had a volatile ride in the week ended May 14, with stocks moving broadly lower for much of the week before coming back up strongly in the final session. Some of the weakness may be traced back to the across-t.....»»
Friday’s Top Analyst Upgrades and Downgrades: Bristol Myers Squibb, Carrier, Comcast, DraftKings, Nvidia, Textron and More
Friday's top analyst upgrades and downgrades included AvalonBay Communities, Bristol-Myers Squibb, Carrier, Comcast, CyrusOne, DraftKings, Nvidia and Textron......»»
The Zacks Analyst Blog Highlights: Bristol-Myers Squibb, BHP, CVS Health, T-Mobile US and Anthem
Zacks.....»»
Bristol-Myers Squibb Reaches Analyst Target Price
Dividend Channel.....»»
Bristol-Myers Squibb Posts Q3 Earnings Beat, Raises Full-Year Guidance
Bristol-Myers Squibb (NYSE: BMY) reported third-quarter earnings of $1.17 per share Thursday, beating the analyst consensus estimate of $1.07. The company reported quarterly sales of $6.007 billion.....»»
Bristol-Myers plans to divest Celgene"s psoriasis drug
Bristol-Myers Squibb Co on Monday offered to divest Celgene Corp's psoriasis treatment Otezla to allay concerns raised by the U.S. competition regulator, and pushed back the closing of their $74 billion deal......»»
Top Analyst Upgrades and Downgrades: Amex, Bristol-Myers, Celgene, Cognizant, EA, Fortinet, Lyft, Target, Tilray, Walmart and More
The top analyst upgrades, downgrades and initiations seen on Friday included American Express, Bristol-Myers Squibb, Celgene, CognizantTechnology Solutions, Electronic Arts, Fortinet, Lyft, Target,........»»
Top Analyst Upgrades and Downgrades: Bristol-Myers, Chesapeake Energy, Coca-Cola, Dropbox, GrubHub, Merck, Netflix, Twitter and More
The top analyst upgrades, downgrades and other research calls from Tuesday include Bristol-Myers Squibb, Chesapeake Energy, Coca-Cola, Dropbox, GrubHub, Merck, National Oilwell Varco, Netflix and........»»
Intraday Update: Dow Jumps 300 Points as Risk Is Back in Style
Stocks are soaring today as earnings results and the lack of a war help boost the market. Also, big moves in Navistar and Bristol Myers Squibb, and keeping an eye on energy......»»
Bristol-Myers Squibb Stock Is Coming Back Slow, but That’s Fine
InvestorPlace - Stock Market News, Stock A.....»»
Gilead Sciences Gets a Boost After Celgene Deal
An analyst upgrade—and renewed interest in biotechs after Bristol-Myers Squibb announced a deal to buy Celgene—have help Gilead’s stock rise......»»
Bristol Myers Squibb to close big Peninsula site, consolidate at another amid company-wide cuts
The company says it will cut 2,200 jobs this year on its way to shedding $1.5 billion in costs by the end of next year......»»
Bristol-Myers Q1 Loss Narrower Than Expected, Sales Beat
Bristol-Myers Squibb Company (NYSE: BMY) reported an adjusted loss per share of $4.40, narrower than the Zacks Consensus Estimate of a loss of $4.53 per share. In the year-ago quarter, BMY posted adjusted earnings per share of $2.05. read more.....»»